Showing results (61-70 of 165) with videos related to

Sort By:
Pageof 17
Zhonghua Nei Ke Za Zhi|July 1, 2024
[Analysis of the correlation between fatty liver index and myocardial remodeling]J C Qu, A P Wang, J T Dou, et al.
Zhonghua Yi Xue Za Zhi|August 27, 2016
[Etiology analysis of 522 hospitalized cases with Cushing syndrome]L L Li, J T Dou, G Q Yang, et al.
Zhonghua Yi Xue Za Zhi|June 20, 2024
[The value of midnight 1 mg dexamethasone suppression test combined with ACTH stimulation test in the diagnosis of primary aldosteronism subtypes]P Qiu, L Zhang, D Y Jiang, et al.
Chemistry and Physics of Lipids|October 26, 1999
The reaction of thiolates with 2,3-dibromo-1-propanol revisited: application to the synthesis of bis(fattyalkylthio)propanolsM D Gernon, J G Turcotte, R H Notter, et al.
Synapse (New York, N.Y.)|August 1, 1995
IPT: a novel iodinated ligand for the CNS dopamine transporterM P Kung, W D Essman, D Frederick, et al.
Zhonghua Nei Ke Za Zhi|September 4, 2025
[Two cases of X-linked adrenoleukodystrophy presenting with Addison's disease as the initial manifestation and analysis of novel ABCD1 variants]Y Q Yin, L Q Li, Y Cheng, et al.
European Journal of Nuclear Medicine|August 7, 1999
Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [(123)I]IDAMP D Acton, M P Kung, M Mu, et al.
Cancer Research|May 15, 1997
Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cellsD He, Z M Mu, X Le, et al.
Molecular and Cellular Endocrinology|December 24, 1997
Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regressionK Liu, Y X Liu, Z Y Hu, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|August 23, 2016
[Status of cholesterol goal attainment for the primary and secondary prevention of atherosclerotic cardiovascular disease in dyslipidemia patients receiving lipid-lowering therapy: DYSIS-China subgroup analysis]Y Li, S P Zhao, P Ye, et al.
Pageof 17